# The Effects of OCP and Metformin on Clinical, Hormonal, Metabolic and Ultrasonographic Characteristics in PCOS

> **NCT02866786** · PHASE4 · COMPLETED · sponsor: **S.C.B. Medical College and Hospital** · enrollment: 101 (actual)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **DRUG:** Metformin
- **DRUG:** ethinyl estradiol and cyproterone acetate

## Key facts

- **NCT ID:** NCT02866786
- **Lead sponsor:** S.C.B. Medical College and Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-15
- **Primary completion:** 2017-04-20
- **Final completion:** 2017-08-01
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2018-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02866786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02866786, "The Effects of OCP and Metformin on Clinical, Hormonal, Metabolic and Ultrasonographic Characteristics in PCOS". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02866786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*